Home Tests Sentis™ Lung Cancer Panel (Tissue, 20 genes)

Sentis™ Lung Cancer Panel (Tissue, 20 genes)

Umm Al Hamam Al Gharbi, Riyadh - 145KM

The Sentis™ Lung Cancer Panel is a precision Next-Generation Sequencing (NGS) test developed by BGI to detect critical genomic alterations in lung cancer using tissue samples. It covers 20 key genes with clinically relevant mutations that help guide personalized treatment strategies.

Key Benefits:

Comprehensive Mutation Detection: Identifies base substitutions, insertions/deletions (InDels), copy number variations (CNVs), and gene fusions.

Actionable Data: Provides molecular insights directly linked to targeted and immunotherapy options.

Flexible Sample Types: Works with fresh tissue, FFPE samples, or extracted tumor DNA.

Reliable & Accurate: Powered by BGI’s advanced sequencing technology for high-quality results.

Disclaimer: You must consult your physician. Test results should always be interpreted in consultation with your treating physician. At Genalive, we provide access to certified genetic counselors who can assist in collecting detailed family history and help identify the most appropriate genetic test for each patient.